X @Forbes
Novo Nordisk(US:NVO) Forbes·2026-07-29 22:00A clinical trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy, can reduce heavy drinking in adults with alcohol use disorder.Read more: https://t.co/aOuK4SLgI9Photo: Michael Siluk/UCG/Universal Images Group via Getty Images ...